GlassScriptPhysician profile
Darrin Douglas Cunningham
NPI 1548262306
$2,428.60
in general payments reported to CMS, 2019-2025
22 companies · none reported in 2025
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $303 · 2020: $359 · 2021: $767 · 2022: $616 · 2023: $241 · 2024: $143.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $309 · Education: $74.99.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $308.81 |
| Education | $74.99 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Abbvie INC. | $917.94 | 2019-2024 | Lo Loestrin Fe, Orilissa |
| Pfizer INC. | $238.83 | 2020-2024 | |
| Exeltis, USA INC. | $173.39 | 2020-2024 | Slynd |
| Mayne Pharma Commercial LLC | $163.92 | 2021-2023 | |
| Astellas Pharma US INC | $159.99 | 2022-2023 | |
| Ethicon US, LLC | $157.08 | 2019-2021 | |
| Organon LLC | $113.35 | 2021-2024 | Nexplanon |
| Hologic Sales and Service, LLC | $91.37 | 2019-2024 | Aptima, Myosure Tissue Removal Device, Novasure |
| Bayer Healthcare Pharmaceuticals INC. | $75.57 | 2019-2024 | |
| Merck Sharp & Dohme LLC | $56.46 | 2019-2021 | |
| Mylan Pharmaceuticals INC. | $46.82 | 2021-2022 | |
| Channel Medsystems, INC. | $37.36 | 2023 | |
| Roche Diagnostics Corporation | $33.92 | 2019 | |
| Boston Scientific Corporation | $30.17 | 2019 | |
| Allergan, INC. | $26.36 | 2019-2020 |
Show all 22 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Sumitomo Pharma America, INC. | $24.70 | 2024 | Myfembree |
| Therapeuticsmd, INC. | $14.75 | 2019 | |
| Coopersurgical, INC. | $14.56 | 2019 | |
| Meditrina | $14.50 | 2022 | |
| Avion Pharmaceuticals | $12.97 | 2022 | |
| Myovant Sciences INC. | $12.94 | 2022 | |
| Amag Pharmaceuticals, INC. | $11.65 | 2019 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Darrin Cunningham listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.